In our April issue

A focus on nanotechnology and global health featuring nanotechnology for infectious diseases and nanomaterial vacine strategies, and many more advances in nano.


Nature Nanotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


    • Twisted bilayer graphene enables the realization of Josephson junctions and single electron transistors in a single, crystalline material using electric field gating only, thereby avoiding interfaces between dissimilar materials.

      • Jonathan R. Prance
      • Moshe Ben Shalom
      News & Views
    • This Perspective aims to place nanoplastics in the context of global plastic pollution by assessing its sources and risks, and by assessing commonalities nanoplastics may share with other nanosized objects in environmental systems.

      • Denise M. Mitrano
      • Peter Wick
      • Bernd Nowack
    • This Perspective examines how the characteristics of nanoplastic impact environmental fate, potential effects on biota and human health, sampling and analysis in a different way from either microplastic or engineered nanomaterials.

      • Julien Gigault
      • Hind El Hadri
      • Mark Wiesner
    • The memristor, in which an external electric field controls the formation and annihilation of conductive channels, has been described both as a missing electronic element and a memory and computational element. Here, their utility as building blocks for promising reflective and energy-efficient colour technology is described.

      • Syed Ghazi Sarwat
      • Harish Bhaskaran
      News & Views
    • The use of phase-change materials makes metasurfaces and nanoantennas electrically tunable and switchable, bringing their functionality to the next level.

      • Sergey Lepeshov
      • Alex Krasnok
      News & Views
  • The nanotechnology-enabled mRNA-based vaccine platform recently approved against COVID-19 bears hope for improved vaccine development and trialling capacities in low- and middle-income countries as part of a broader global public health agenda.

    • Steffi Friedrichs
    • Diana M. Bowman
  • To achieve the biggest impact, nanotechnology-based strategies developed to manage infectious diseases in resourced-limited settings need to take into account the local context.

  • Sharing protocols with the end-users may allow their flexible implementation to produce nanotechnology solutions for global health challenges that better cater for local needs.

    • Jose Gomez-Marquez
    • Kimberly Hamad-Schifferli
  • When developing nanotechnology solutions for global health it is important to be mindful of the ethical, environmental, socio-economical, cultural and legal aspects associated with their deployment.

    • Fabio Salamanca-Buentello
    • Abdallah S. Daar
  • We have launched a series of webinars to engage our audience in a way that is complementary to the publication of articles.

When nanotechnology focuses on COVID-19

When nanotechnology focuses on COVID-19

In face of the coronavirus pandemic, the nanotechnology community has joined forces to provide tools and expertise to COVID-19 research efforts. Long-term experience in drug delivery, nanovaccines, immunoengineering, biosensors and platform technologies positions nanotechnology in a unique place to tackle some of the key issues in preclinical and clinical COVID-19 research

Nature Careers